US Stock MarketDetailed Quotes

GDTC CytoMed Therapeutics

Watchlist
  • 2.200
  • -0.010-0.46%
Close Nov 21 16:00 ET
  • 2.200
  • 0.0000.00%
Post 20:01 ET
25.39MMarket Cap-10837P/E (TTM)

CytoMed Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CytoMed Therapeutics H1 FY2024 Earnings Date

Currency：SGDOct 8, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
0
--
--
EPS
--
-0.09
--
+51.92%
Analyst Rating
No Data

CytoMed Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Oct 8, 20242024/Q2-- / 156.000K--
--2024/Q1-- / 156.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--
DatePeriodRevenue/EstimateEarnings Call
Oct 8, 20242024/Q2-- / 156.000K--
--2024/Q1-- / 156.000K--
--2023/Q4-- / 130.000K--
--2023/Q3-- / 130.000K--
Nov 22, 20232023/Q2-- / 130.000K--

Unlock Free Earnings Estimates

CytoMed Therapeutics Earnings Reports

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 30 07:03 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    May 24 11:16 ET

  • CytoMed Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)

    Apr 25 15:36 ET

  • CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 24 16:19 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data